| Funding opportunities and news for global health researchers from the Fogarty International Center at the U.S. National Institutes of Health. 
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Funding Opportunities NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. - NIH's National Heart, Lung, and Blood Institute (NHLBI) Hope for Sickle Cell Disease Challenge aims to help increase awareness about sickle cell disease and its associated complications.
Note: Non-U.S. citizens and non-permanent residents can participate as part of a team and receive recognition, but are not eligible to win monetary prizes.
Submission deadline: March 26, 2021
Notice of Technical Assistance Webinar for NHLBI Hope for Sickle Cell Disease Challenge (NOT-HL-21-001) on February 3, 2021. Advance registration required. - Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) (PA-21-110)
Application Receipt Dates: February 16, 2021, March 16, 2021, May 07, 2021 and more - Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R21 Clinical Trial Not Allowed) (PAR-21-062)
Application Receipt Dates: Standard AIDS dates apply. - Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) (RFA-AG-21-034)
Application Receipt Date: March 31, 2021 - Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) (RFA-AI-20-077)
Application Receipt Dates: June 4, 2021 - NIH's Helping to End Addiction Long-term (HEAL) Initiative: HEALthy Brain and Child Development Study:
Collaborative Cooperative Agreements (U01 Clinical Trial Not Allowed) (RFA-DA-21-020)
Cooperative Agreements (U01 - Clinical Trial Not Allowed) (RFA-DA-21-021)
Consortium Administrative Core (U24 - Clinical Trial Not Allowed) (RFA-DA-21-022)
Data Coordinating Center (U24) (RFA-DA-21-023)
Application Receipt Date: March 31, 2021 - Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) (RFA-DK-21-001)
Application Receipt Dates: April 22, 2021, November 3, 2021 - BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (RFA-EY-21-001)
Application Receipt Dates: May 3, 2021; October 29, 2021; and more | Featured Fogarty News and Information NIH COVID-19 Funding and News | Funding News NIH funding news that may be relevant to global health researchers. - Request for Information (RFI): Inviting Comments and Suggestions on the Identification of Key Events in Autoimmune Diseases (NOT-AI-21-015)
- BRAIN Initiative: Request for Information (RFI) on Development and Dissemination of Human Brain Imaging Technologies (NOT-NS-21-024)
Upcoming Deadlines
| This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH · National Institutes of Health · Bethesda, MD 20892 · (301) 496-2075 · ficinfo@mail.nih.gov |  | |
No comments:
Post a Comment